Tirzepatide is a synthetic peptide developed by Eli Lilly that mimics two natural gut hormones — glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). By activating both pathways simultaneously, it achieves blood sugar control and appetite suppression that outperforms medications targeting only one hormone. It was FDA-approved for type 2 diabetes in 2022 (as Mounjaro) and for chronic weight management in 2023 (as Zepbound).

After eating, your gut naturally releases GIP and GLP-1, which signal the pancreas to release insulin, tell your brain you are full, and slow the rate at which your stomach empties. Tirzepatide activates both of these receptors at once, producing stronger and more sustained signals for satiety and blood sugar regulation than either hormone alone. The result is that people feel full sooner, eat less, and their bodies handle blood sugar more efficiently.

Available as a subcutaneous injection in pre-filled single-dose pens. Dose strengths include 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Injected once weekly into the abdomen, thigh, or upper arm. Does not require refrigeration for up to 21 days at room temperature.

• Type 2 diabetes
• Weight loss and obesity
• Metabolic syndrome
• High blood sugar (hyperglycemia)
• High triglycerides
• High blood pressure
• Non-alcoholic fatty liver disease (NAFLD)
• Binge eating and food cravings
• Prediabetes
• Obstructive sleep apnea

• Progression from prediabetes to type 2 diabetes
• Cardiovascular events in adults with type 2 diabetes and high cardiovascular risk (emerging evidence from SURMOUNT-MMO trial program)
• Worsening of non-alcoholic fatty liver disease
• Obesity-related complications (high blood pressure, dyslipidemia, joint stress)

Tirzepatide is a synthetic injectable peptide and is not found in any food. However, certain dietary patterns strongly support the same biological goals. Eating high-protein meals (eggs, fish, legumes, Greek yogurt) naturally stimulates GLP-1 release and helps you feel full longer. High-fiber foods like vegetables, oats, and lentils slow glucose absorption and feed gut bacteria that produce their own GLP-1-stimulating short-chain fatty acids. Fermented foods (kefir, kimchi, sauerkraut) support the gut microbiome, which influences incretin hormone production. Limiting ultra-processed foods, added sugars, and refined carbohydrates reduces the metabolic burden tirzepatide is designed to address. A Mediterranean-style eating pattern pairs particularly well with tirzepatide therapy to maximize and sustain results.

• Nausea (most common, especially when starting or increasing dose)
• Vomiting
• Diarrhea
• Constipation
• Reduced appetite (usually a desired effect)
• Stomach discomfort or bloating
• Injection site redness or irritation
• Fatigue (often temporary during early weeks)
• Low blood sugar (hypoglycemia) — mainly when combined with insulin or sulfonylureas
• Hair loss (telogen effluvium from rapid weight loss — typically temporary)
• Rare: pancreatitis — stop use and seek care if severe abdominal pain occurs
• Rare: gallbladder problems — rapid weight loss increases gallstone risk
• Rare: allergic reaction — seek emergency care for difficulty breathing, swelling, or rash
• Rare: thyroid C-cell tumors — contraindicated in those with personal or family history of medullary thyroid cancer or MEN2 syndrome (animal data; human risk unconfirmed but the contraindication stands)

• Recommended daily: Starting dose: 2.5 mg once weekly for 4 weeks. Then increase to 5 mg once weekly. Dose is escalated in 2.5 mg increments every 4 weeks as tolerated, up to a maximum of 15 mg once weekly. Most therapeutic benefit for weight loss occurs at 10-15 mg weekly.
• Best time of day: Any consistent day of the week at any time of day. Picking the same day each week (e.g., every Sunday morning) improves adherence.
• With or without food: Can be injected with or without food. Many users find injecting on an empty stomach or a few hours before a large meal helps minimize nausea.
• Time to effect: Blood sugar improvement: 1-2 weeks. Noticeable weight loss: 8-12 weeks. Maximum effect: 6-12 months of consistent use.
• How long to take it: Intended for long-term, ongoing use. Weight and blood sugar typically return toward baseline within months of stopping. Discontinuation should always be discussed with a prescribing physician — do not stop abruptly without a plan.